Press release
Investigation announced for Investors in shares of Grifols, S.A. (NASDAQ: GRFS) over possible Violations of Securities Laws
An investigation for investors in Grifols, S.A. (NASDAQ: GRFS) shares over potential securities laws violations by Grifols, S.A.
Investors who purchased shares of Grifols, S.A. (NASDAQ: GRFS), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm focuses on whether a series of statements by Grifols, S.A. (NASDAQ: GRFS regarding its business, its prospects and its operations were materially false and misleading at the time they were made.
Barcelona, Spain based Grifols, S.A. operates as a plasma therapeutic company in Spain, the United States, Canada and internationally. Grifols, S.A. reported that its annual Total Revenue rose from over 4.93 billion EUR in 2021 to over 6.06 billion EUR in 2022, and that its Net Income increased from $188.72 million in 2021 to $208.27 million in 2022.
On January 9, 2024, Gotham City Research LLC published a short-seller report on Grifols SA. In the report, Gotham City alleged, among other things, the stock market "appears to fundamentally misunderstand the company." The report claimed that Grifols "artificially reduced leverage by consolidating earnings of units it doesn't control and has overstated profit." Further stating, "GRF manipulates reported debt & EBITDA to artificially reduce reported leverage to 6x which we believe is closer to 10x-13x."
Shares of Grifols, S.A. (NASDAQ: GRFS) declined from $10.83 per share on December 14, 2023, to as low as $6.78 per share on January 18, 2024.
Those who purchased shares of Grifols, S.A. (NASDAQ: GRFS) have certain options and should contact the Shareholders Foundation.
Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com
About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Investigation announced for Investors in shares of Grifols, S.A. (NASDAQ: GRFS) over possible Violations of Securities Laws here
News-ID: 3411033 • Views: …
More Releases from Shareholders Foundation
ALERT: Lawsuit filed for Investors who SOLD shares of Sina Corporation (formerly …
An investor, who sold shares of Sina Corporation (formerly NASDAQ: SINA) in the merger between Seina Corporation and TuSimple Holdings, Inc, filed a lawsuit over alleged violations of Federal Securities Laws by Sina Corporation (formerly NASDAQ: SINA in connection with certain allegedly false and misleading statements made.
If you sold a significant amount of shares of Sina Corporation (formerly NASDAQ: SINA) between October 13, 2020 and March 22, 2021, you have…
Lawsuit Alert: Investors who lost money with shares of Fluor Corporation (NYSE: …
An investor, who purchased shares of Fluor Corporation (NYSE: FLR), filed a lawsuit alleged violations of Federal Securities Laws by Fluor Corporation in connection with certain allegedly false and misleading statements.
Investors who purchased shares of Fluor Corporation (NYSE: FLR) have certain options and for certain investors are short and strict deadlines running. Deadline: November 14, 2025. NYSE: FLR investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779…
Investigation announced for Long-Term Investors in shares of Sable Offshore Corp …
An investigation was announced for long-term investors in shares of Sable Offshore Corp. (NYSE: SOC) concerning potential breaches of fiduciary duties by certain directors of Sable Offshore Corp.
Investors who are current long term investors in Sable Offshore Corp. (NYSE: SOC) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term investors in…
Lawsuit filed for Investors who lost money with shares of Lantheus Holdings, Inc …
An investor, who purchased shares of Lantheus Holdings, Inc. (NASDAQ: LNTH), filed a lawsuit over alleged violations of Federal Securities Laws by Lantheus Holdings, Inc. in connection with certain allegedly false and misleading statements.
Investors who purchased shares of Lantheus Holdings, Inc. (NASDAQ: LNTH) have certain options and for certain investors are short and strict deadlines running. Deadline: November 10, 2025. NASDAQ: LNTH investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com…
More Releases for Grifols
Plasma Fractionation Market Is Booming Worldwide | Grifols, Kedrion, Sanquin
The "Plasma Fractionation Market" intelligence report, just published by USD Analytics Market, covers a micro-level study of important market niches, product offers, and sales channels. to determine market size, potential, growth trends, and competitive environment, the Plasma Fractionation Market provides dynamic views. Both primary and secondary sources of data were used to generate the research, which has both qualitative and quantitative depth. Several of the major figures the study featured…
Fibrin Sealants Market Is Booming Worldwide | Dickinson, Grifols, Nordson
The "Fibrin Sealants Market" intelligence report, just published by USD Analytics Market, covers insurers' micro-level study of important market niches, product offers, and sales channels. In order to determine market size, potential, growth trends, and competitive environment, the Fibrin Sealants Market provides dynamic views. Both primary and secondary sources of data were used to generate the research, which has both qualitative and quantitative depth. Several of the major figures the…
Blood Bag Systems Market | AdvaCare, Fresenius, Grifols, Haemonetics
The global blood bag systems market report is a comprehensive report that provides a detailed analysis of the current status and future trends of the blood bag systems market worldwide. This report provides valuable information to industry stakeholders by offering an in-depth perspective on market dynamics, competitive landscape, growth opportunities, and key challenges faced by industry participants.
From the perspective of market dynamics, this report explores the factors driving the growth…
Blood Collection Bags Market | AdvaCare, Fresenius, Grifols, HLL Lifecare
The global blood collection bags market report is a comprehensive report that provides a detailed analysis of the current status and future trends of the blood collection bags market worldwide. This report provides valuable information to industry stakeholders by offering an in-depth perspective on market dynamics, competitive landscape, growth opportunities, and key challenges faced by industry participants.
From the perspective of market dynamics, this report explores the factors driving the growth…
Hemophilia Drugs Market is Thriving Worldwide with Grifols, Octapharma, Pfizer
The Latest Released Hemophilia Drugs market study has evaluated the future growth potential of Hemophilia Drugs market and provides information and useful stats on market structure and size. The report is intended to provide market intelligence and strategic insights to help decision-makers take sound investment decisions and identify potential gaps and growth opportunities. Additionally, the report also identifies and analyses changing dynamics, and emerging trends along with essential drivers, challenges,…
Pharmaceutical Contract Manufacturing & Contract Market with Global Innovations, …
ResearchMoz include new market research report "Global Pharmaceutical Contract Manufacturing & Contract Market Size,Status and Forecast 2025" to its huge collection of research reports.
This report studies the global Pharmaceutical Contract Manufacturing & Contract market, analyzes and researches the Pharmaceutical Contract Manufacturing & Contract development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like
Catalent
Pharmaceutical Product Development…
